Physician profile
Anu Batra
NPI 1720386857
$30,241.75
in general payments reported to CMS, 2019-2025
78 companies · $7,661 in 2025
The $7,661 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,682 · 2020: $872 · 2021: $706 · 2022: $2,776 · 2023: $4,497 · 2024: $12K · 2025: $7,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $9,935 · Education: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,875.00 |
| Food and Beverage | $9,934.55 |
| Education | $396.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $9,870.32 | 2020-2025 | Enhertu, Datroway, Injectafer |
| Astrazeneca Pharmaceuticals Lp | $4,573.54 | 2019-2025 | Calquence, Lynparza, Imfinzi |
| Janssen Biotech, INC. | $2,164.72 | 2019-2025 | Darzalex, Erleada, Tecvayli |
| Novartis Pharmaceuticals Corporation | $1,179.21 | 2019-2025 | |
| Pfizer INC. | $958.40 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $894.43 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $881.05 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Genentech USA, INC. | $537.07 | 2019-2025 | Polivy, Tecentriq, Phesgo |
| Abbvie INC. | $526.68 | 2019-2025 | Creon, Venclexta |
| Amgen INC. | $505.29 | 2019-2023 | Kyprolis, Nplate, Vectibix |
| E.R. Squibb & Sons, L.L.C. | $500.91 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Eisai INC. | $485.97 | 2019-2025 | |
| Genzyme Corporation | $476.65 | 2019-2025 | |
| Seagen INC. | $471.32 | 2020-2025 | Tukysa, Adcetris, Padcev |
| Astellas Pharma US INC | $370.85 | 2019-2025 | Xtandi, Padcev, Xospata |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $329.75 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Takeda Pharmaceuticals U.S.A., INC. | $275.77 | 2019-2025 | Alunbrig, Iclusig, Ninlaro |
| Pharmacyclics LLC, An Abbvie Company | $258.15 | 2019-2023 | Imbruvica, Epkinly |
| Array Biopharma INC | $254.08 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Incyte Corporation | $230.56 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Gilead Sciences, INC. | $226.49 | 2022-2025 | Trodelvy |
| Exelixis INC. | $223.45 | 2019-2025 | Cabometyx |
| Bayer Healthcare Pharmaceuticals INC. | $218.10 | 2019-2025 | |
| Blueprint Medicines Corporation | $199.89 | 2020-2025 | Ayvakit |
| Alexion Pharmaceuticals, INC. | $197.55 | 2022-2025 | Ultomiris |
| Regeneron Healthcare Solutions, INC. | $179.68 | 2021-2025 | Libtayo |
| Ipsen Biopharmaceuticals, INC | $177.07 | 2020-2025 | Onivyde, Tazverik |
| Springworks Therapeutics, INC. | $174.42 | 2024-2025 | Ogsiveo |
| Puma Biotechnology, INC. | $168.37 | 2019-2025 | |
| Kite Pharma, INC. | $151.52 | 2022-2025 | Yescarta |
| Beone Medicines USA, INC. | $148.06 | 2025 | Tevimbra, Brukinsa |
| Emd Serono, INC. | $136.58 | 2019-2025 | Tepmetko |
| Tempus Ai, INC | $133.46 | 2024-2025 | Xt Cdx |
| Aveo Pharmaceuticals, INC. | $132.49 | 2022-2025 | Fotivda |
| Lilly USA, LLC | $131.58 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Jazz Pharmaceuticals INC. | $129.72 | 2022-2025 | Zepzelca |
| Rigel Pharmaceuticals, INC. | $125.93 | 2021-2024 | Rezlidhia, Tavalisse |
| Beigene USA, INC. | $121.71 | 2023-2024 | Brukinsa |
| Tersera Therapeutics LLC | $99.34 | 2022-2024 | Zoladex |
| Taiho Oncology, INC. | $96.43 | 2022-2024 | |
| Stemline Therapeutics INC. | $95.80 | 2023-2025 | Orserdu |
| Chiesi USA, INC. | $78.09 | 2022-2025 | Ferriprox |
| Sobi, INC | $77.22 | 2023-2025 | |
| Adc Therapeutics America, INC. | $69.47 | 2024 | |
| Karyopharm Therapeutics INC. | $54.15 | 2022 | |
| Global Blood Therapeutics, INC. | $53.29 | 2022 | |
| Myovant Sciences INC. | $51.69 | 2022 | |
| Sumitomo Pharma America, INC. | $46.41 | 2024 | Orgovyx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.91 | 2019 | |
| Cti Biopharma Corp. | $41.54 | 2023 | Vonjo |
| Davol INC. | $41.22 | 2024 | Progel Applicator Spray Tips |
| Adaptive Biotechnologies Corporation | $39.27 | 2022-2025 | Clonoseq |
| Mirati Therapeutics, INC. | $37.98 | 2023 | Krazati |
| Deciphera Pharmaceuticals INC. | $37.28 | 2023-2024 | Qinlock |
| Organon LLC | $35.73 | 2022 | |
| Geron Corporation | $33.52 | 2025 | Rytelo |
| Janssen Pharmaceuticals, INC | $32.73 | 2023-2025 | Xarelto |
| Morphosys, US INC. | $32.42 | 2022-2023 | Monjuvi |
| Epizyme, INC. | $29.41 | 2020-2021 | |
| Tesaro, INC. | $28.69 | 2019 | |
| Coherus Oncology, INC. | $27.25 | 2025 | Loqtorzi |
| Legend Biotech USA INC. | $27.01 | 2025 | Carvykti |
| Kyowa Kirin, INC. | $26.53 | 2025 | |
| Eusa Pharma (US) LLC | $24.88 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $24.75 | 2019 | |
| Iovance Biotherapeutics, INC. | $23.68 | 2025 | Amtagvi |
| Agios Pharmaceuticals, INC. | $22.67 | 2025 | Pyrukynd |
| Servier Pharmaceuticals LLC | $21.22 | 2022 | |
| Immunocore Limited | $21.06 | 2025 | Kimmtrak |
| Verity Pharmaceuticals INC. | $21.00 | 2024 | Trelstar |
| Dova Pharmaceuticals | $18.81 | 2021 | |
| Recordati_rare_diseases_inc. | $18.49 | 2025 | Enjaymo |
| Sun Pharmaceutical Industries INC. | $18.33 | 2023 | Odomzo, Yonsa |
| Emmaus Medical, INC. | $16.98 | 2023 | Endari |
| Helsinn Therapeutics (U.S.), INC. | $13.77 | 2019 | |
| Shorla Oncology INC. | $13.56 | 2025 | |
| Pharmacosmos Therapeutics INC. | $12.84 | 2020 | |
| Verastem, INC. | $11.54 | 2019 |
Drugs and devices associated with these payments
Calquence $3,733Enhertu $1,720Datroway $478Reblozyl $459Keytruda $423Imbruvica $398Tukysa $328Darzalex $286Elrexfio $285Epkinly $242Lynparza $241Lenvima $220Xtandi $219Ibrance $219Kisqali $211Opdivo $203Polivy $192Adcetris $180Braftovi $180Ogsiveo $174Ultomiris $165Ayvakit $163Venclexta $161Brukinsa $158Mektovi $158Orgovyx $156Libtayo $148Ojjaara $146Tecentriq $141Fabhalta $135Scemblix $133Jemperli $127Talzenna $126Verzenio $119Xt Cdx $115Erleada $115Vitrakvi $111Tecvayli $103Lorbrena $101Carvykti $101Yescarta $99.27Rezlidhia $98.69Tavalisse $98.69Vonjo $96.13Orserdu $95.80Fotivda $92.18Balversa $90.80Jakafi $90.09Onivyde $88.39Pluvicto $86.73Xalkori $86.18Padcev $84.11Tevimbra $83.43Zoladex $83.38Stivarga $83.27Phesgo $79.67Alunbrig $78.70Inqovi $76.01Lonsurf $76.01Lunsumio $75.23Columvi $75.23Sarclisa $73.88Tabrecta $73.79Bosulif $70.42Ziihera $69.29Akeega $68.04Cabometyx $66.22Alecensa $64.25Rozlytrek $64.25Oxbryta $61.26Inlyta $59.20Talvey $58.62Welireg $56.19Lutathera $56.16Ferriprox $55.95Monjuvi $53.73Tasigna $51.56Itovebi $49.96Jevtana $48.01Zejula $48.00Enjaymo $47.29Zepzelca $47.23Iclusig $46.33Trodelvy $44.58Opdualag $44.06Imfinzi $43.12Mekinist $43.07Jaypirca $42.66Ninlaro $41.62Progel Applicator Spray Tips $41.22Tazverik $39.33Pomalyst $37.99Krazati $37.98Qinlock $37.28Xospata $36.53Tepmetko $35.60Gavreto $34.54Paxlovid $34.13Tecentriq Hybreza $33.59Rytelo $33.52
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anu Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.